Literature DB >> 8838494

Ontogeny and characterization of factor XIIIa+ cells in developing human skin.

N S Gibran1, B J Nickoloff, K A Holbrook.   

Abstract

Factor XIIIa (FXIIIa), a coagulation transglutaminase, is a cytoplasmic marker for dermal dendritic cells reported to be bone marrow-derived, phagocytic and antigen-presenting. In non-inflamed skin, these cells populate the papillary dermis in a perivascular distribution. They are increased in dermatoproliferative disorders and have been implicated as dermal stimulants for psoriatic hyperkeratosis. Since developing skin provides an example of dermal influence on the epidermis, we evaluated the presence of FXIIIa+ cells in human fetal skin to determine whether their location would suggest a role in morphogenetic events in the skin. Embryonic and fetal skin of progressive estimated gestational ages (EGA) was examined using immunocytochemistry with a polyclonal antibody to FXIIIa. At 6 weeks EGA, globular FXIIa+ cells were present in the hypodermis. By 7-8 weeks, a compact sub-epidermal network of fusiform FXIIIa+ cells was also evident. By 11-12 weeks, the sub-epidermal cellular network was no longer FXIIIa+, but discrete FXIIIa+ dendritic cells were present in the reticular dermis. With advancing gestational age, FXIIIa+ dendritic cells populated the papillary dermis in a perivascular distribution. This adult-like distribution persisted through 22 weeks EGA, the oldest specimen examined. Because FXIIIa+ cells were evident in embryonic skin before the onset of bone marrow hematopoietic function, the skin was double-labeled with the FXIIIa antibody and with monoclonal antibodies to CD45 (marker for bone marrow-derived cells), CD68 (marker for macrophages) and HLA-DR (class II major histocompatibility antigen). Most of the FXIIIa+ dendritic cells did not colocalize CD45, but were CD68+; some cells did react with the HLA-DR antibody. Notably, the FXIIIa+ cells of the sub-epidermal network in the 7 weeks EGA specimens did not react with the other antibodies. We conclude that FXIIIa+ cells are first present in embryonic hypodermis and sub-epidermal dermis and later they are distributed in the papillary dermis in a perivascular pattern. In embryonic skin FXIIIa+ cells are not exclusively dendritic. Our data support the idea that cells that express FXIIIa do not constitute a unique bone marrow-derived cell type, but that multiple cell types produce FXIIIa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838494     DOI: 10.1007/bf00186831

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  29 in total

1.  Organization of the monocyte/macrophage system of normal human skin.

Authors:  K Weber-Matthiesen; W Sterry
Journal:  J Invest Dermatol       Date:  1990-07       Impact factor: 8.551

2.  "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Authors:  M Piacentini; F Autuori; L Dini; M G Farrace; L Ghibelli; L Piredda; L Fesus
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

3.  Relationship of factor XIIIa-positive dermal dendrocytes to Kaposi's sarcoma.

Authors:  M H Gray; C L Trimble; J Zirn; N S McNutt; B R Smoller; M Varghese
Journal:  Arch Pathol Lab Med       Date:  1991-08       Impact factor: 5.534

4.  Factor XIIIa positivity in fibrous papule.

Authors:  R Cerio; E W Jones
Journal:  J Am Acad Dermatol       Date:  1990-01       Impact factor: 11.527

5.  Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin.

Authors:  R Cerio; C E Griffiths; K D Cooper; B J Nickoloff; J T Headington
Journal:  Br J Dermatol       Date:  1989-10       Impact factor: 9.302

6.  Factor XIIIa is expressed by fibroblasts in fibrovascular tumors.

Authors:  A J Nemeth; N S Penneys
Journal:  J Cutan Pathol       Date:  1989-10       Impact factor: 1.587

7.  Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study.

Authors:  Z Nemes; V Thomázy
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

8.  Identification of factor XIIIa in cutaneous tissue.

Authors:  R Cerio; J Spaull; E W Jones
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

9.  Factor XIIIa in the hamartomas of tuberous sclerosis.

Authors:  N S Penneys; K J Smith; A J Nemeth
Journal:  J Dermatol Sci       Date:  1991-01       Impact factor: 4.563

10.  The distribution of factor XIIIa-positive cells in the human fetus and placenta.

Authors:  C L Trimble; M H Gray; N S McNutt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more
  3 in total

1.  Phenotypic characterization of leukocytes in prenatal human dermis.

Authors:  Christopher Schuster; Christine Vaculik; Marion Prior; Christian Fiala; Michael Mildner; Wolfgang Eppel; Georg Stingl; Adelheid Elbe-Bürger
Journal:  J Invest Dermatol       Date:  2012-06-21       Impact factor: 8.551

2.  HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells.

Authors:  Christopher Schuster; Christine Vaculik; Christian Fiala; Simone Meindl; Oliver Brandt; Martin Imhof; Georg Stingl; Wolfgang Eppel; Adelheid Elbe-Bürger
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

3.  Angiogenic Potential of Human Neonatal Foreskin Stromal Cells in the Chick Embryo Chorioallantoic Membrane Model.

Authors:  Radhakrishnan Vishnubalaji; Muhammad Atteya; May Al-Nbaheen; Richard O C Oreffo; Abdullah Aldahmash; Nehad M Alajez
Journal:  Stem Cells Int       Date:  2015-06-29       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.